Daily Low-Dose Aspirin May Cut Pancreatic Cancer Risk

TUESDAY, Dec. 20, 2016 (HealthDay News) -- There's evidence that daily low-dose aspirin may decrease the risk of pancreatic cancer, according to a new study.

Ovarian Cancer Drug Given Fast-Track Approval

MONDAY, Dec. 19, 2016 (HealthDay News) -- The anti-cancer drug Rubraca (rucaparib) has been granted accelerated approval by the U.S. Food and Drug Administration to treat advanced ovarian cancer.

Chemo More Damaging to Hearts of Diabetics: Study

FRIDAY, Dec. 16, 2016 (HealthDay News) -- A small study finds that cancer patients who have diabetes may suffer worse heart damage from chemotherapy, potentially boosting their risk of heart failure.

Minority Women Less Likely to Get Breast Cancer Screening

FRIDAY, Dec. 16, 2016 (HealthDay News) -- Black and Hispanic women are less likely than white women to be screened for breast cancer, a large review finds.

Angelina Jolie's Mastectomies Tied to Rise in Genetic Testing

THURSDAY, Dec. 15, 2016 (HealthDay News) -- After actress Angelina Jolie had both breasts removed because she faced a heightened risk for breast cancer, there was a spike in the number of women who were tested for the genes that raise that risk. But, there was no corresponding increase in mastectomy rates, researchers report.

Many Early Colon Cancers Linked to Inherited Genes

THURSDAY, Dec. 15, 2016 (HealthDay News) -- As many as 1 in 6 colon cancer patients under the age of 50 has genetic traits that greatly boost the risk of cancer, a new study finds.

Beating Breast Cancer But Still Paying a Price

THURSDAY, Dec. 15, 2016 (HealthDay News) -- Women who survive breast cancer often experience lingering physical and emotional symptoms that go untreated, new research suggests.

A Little Training Helps Couples Ease Into Skin Cancer Checks

WEDNESDAY, Dec. 14, 2016 (HealthDay News) -- Skin cancer checks between couples don't have to be a puzzle -- or embarrassing, a new study shows.

Some Low-Income, Uninsured Patients Aren't Referred for Colonoscopy

TUESDAY, Dec. 13, 2016 (HealthDay News) -- Many low-income and uninsured patients don't have a follow-up colonoscopy after abnormal results on a colon cancer screening test -- even if they're in a "safety net" health program, a new study finds.

Immune-Focused Drug Shows Promise Against Lung Cancer

TUESDAY, Dec. 13, 2016 (HealthDay News) -- An immunotherapy drug called Tecentriq (atezolizumab) extended the survival of lung cancer patients for several months longer than chemotherapy and caused fewer side effects, according to a new study.